GRIFFIN ASSET MANAGEMENT, INC.

Position in SMMT — Summit Therapeutics Inc.

CIK 883803 New York, NY

Position in SMMT

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,820,489

-$817,404 QoQ

Shares Held

193,582

+0.9% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#61

of 242 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GRIFFIN ASSET MANAGEMENT, INC. holds $6,668,181 across 5 Biotechnology names. SMMT ranks #2 (42.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,142	$3,050,915
2	SMMT	Summit Therapeutics Inc. This page	193,582	$2,820,489
3	ABSI	Absci Corp	56,760	$657,848
4	BMEA	Biomea Fusion, Inc.	59,800	$87,906
5	SANA	Sana Biotechnology, Inc.	14,620	$51,023

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,820,489	193,582	+0.9%	Shares	Sole	2026-07-23
2026-03-31	$3,637,893	191,872	-1.9%	Shares	Sole	2026-04-30
2025-12-31	$3,420,117	195,547	+39.4%	Shares	Sole	2026-02-06
2025-09-30	$2,898,226	140,282	+17.5%	Shares	Sole	2025-10-16
2025-06-30	$2,540,448	119,382	+1.9%	Shares	Sole	2025-07-25
2025-03-31	$2,260,980	117,210	+5.9%	Shares	Sole	2025-04-16
2024-12-31	$1,974,727	110,660	+63.3%	Shares	Sole	2025-01-22
2024-09-30	$1,483,944	67,760	—	Shares	Sole	2024-10-15
No filing history on record for this holder in this stock.